Home › Therapeutic areas › Neurology › CLN2 Batten Disease
CLN2 Batten Disease (1 companies)
Companies with an active program in CLN2 Batten Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | CardiovascularNeurology Rare | 1 | Phase 1 | 10 |
No companies match.